-
公开(公告)号:US11053250B2
公开(公告)日:2021-07-06
申请号:US16537385
申请日:2019-08-09
Applicant: Gilead Sciences, Inc.
Inventor: Stephen Ammann , Elizabeth M. Bacon , Gediminas Brizgys , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Marilyn Ndukwe , James G. Taylor , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
IPC: C07D487/04 , A61K31/5025 , A61P29/00
Abstract: A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
-
公开(公告)号:US11046686B2
公开(公告)日:2021-06-29
申请号:US16539834
申请日:2019-08-13
Applicant: Gilead Sciences, Inc.
Inventor: Stephen Ammann , Elizabeth M. Bacon , Gediminas Brizgys , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Marilyn Ndukwe , Marina Shatskikh , James G. Taylor , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
IPC: C07D471/04 , C07D487/04
Abstract: A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
-
公开(公告)号:US20160108030A1
公开(公告)日:2016-04-21
申请号:US14771779
申请日:2014-02-28
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Eda Canales , Chien-Hung Chou , Michael Graupe , Yunfeng Eric Hu , Scott E. Lazerwith , John O. Link , Qi Liu , Yafan Lu , Roland D. Saito , Scott D. Schroeder , John R. Somoza , Winston C. Tse , Jennifer R. Zhang
IPC: C07D471/04 , A61K45/06 , C07D401/14 , A61K31/517 , A61K31/4439 , C07D417/14 , A61K31/506 , A61K31/4709 , C07D413/14 , A61K31/496 , A61K31/5377 , C07D491/052 , A61K31/444 , C07D401/12
CPC classification number: C07D401/12 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D401/04 , C07D401/14 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/052
Abstract: Compounds of formula (I) or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Abstract translation: 公开了式(I)化合物或其盐。 还公开了包含式I化合物的药物组合物,制备式I化合物的方法,可用于制备式I化合物的中间体和用于治疗包括HIV病毒引起的感染的逆转录病毒科病毒感染的治疗方法。
-
公开(公告)号:US09050344B2
公开(公告)日:2015-06-09
申请号:US14151758
申请日:2014-01-09
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Chien-Hung Chou , Randall L. Halcomb , Yunfeng Eric Hu , Qi Liu , John R. Somoza , Winston C. Tse , Jennifer R. Zhang
IPC: A61K31/5377 , C07D401/14 , C07D401/12 , C07D403/14 , A61K31/4439 , A61K31/444 , A61K31/506 , A61K45/06 , C07D403/12 , C07D405/14 , C07D491/107
CPC classification number: A61K31/5377 , A61K31/4439 , A61K31/444 , A61K31/506 , A61K45/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D491/107
Abstract: Compounds of formula I: or pharmaceutically acceptable salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Abstract translation: 公开了式I化合物或其药学上可接受的盐。 还公开了包含式I化合物的药物组合物,制备式I化合物的方法,可用于制备式I化合物的中间体和用于治疗包括HIV病毒引起的感染的逆转录病毒科病毒感染的治疗方法。
-
公开(公告)号:US20220267302A1
公开(公告)日:2022-08-25
申请号:US17584643
申请日:2022-01-26
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Eda Canales , Chienhung Chou , Michael Graupe , Jiayao Li , Roland D. Saito , Scott D. Schroeder , Winston C. Tse , Qiaoyin Wu , Jennifer R. Zhang
IPC: C07D401/14 , A61P31/18 , C07D405/14 , C07D413/14
Abstract: The invention provides compounds having Formula (I): or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.
-
公开(公告)号:US20210214363A1
公开(公告)日:2021-07-15
申请号:US17110734
申请日:2020-12-03
Applicant: Gilead Sciences, Inc.
Inventor: Stephen Ammann , Elizabeth M. Bacon , Gediminas Brizgys , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Marilyn Ndukwe , James G. Taylor , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
IPC: C07D487/04
Abstract: A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.
-
公开(公告)号:US20210009555A1
公开(公告)日:2021-01-14
申请号:US16882804
申请日:2020-05-26
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Eda Canales , Chien-Hung Chou , Michael Graupe , Randall L. Halcomb , Yunfeng Eric Hu , Scott E. Lazerwith , John O. Link , Qi Liu , Yafan Lu , Roland D. Saito , Scott D. Schroeder , John R. Somoza , Winston C. Tse , Jennifer R. Zhang
IPC: C07D401/12 , C07D401/14 , C07D403/14 , C07D471/04 , A61K31/437 , A61K31/4439 , A61K31/444 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D491/052 , C07D401/04 , C07D413/14 , C07D417/14 , C07D487/04
Abstract: Compounds of formula (I) or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
-
公开(公告)号:US20200071333A1
公开(公告)日:2020-03-05
申请号:US16539753
申请日:2019-08-13
Applicant: Gilead Sciences, Inc.
Inventor: Stephen Ammann , Elizabeth M. Bacon , Gediminas Brizgys , Elbert Chin , Chienhung Chou , Jeromy J. Cottell , Marilyn Ndukwe , James G. Taylor , Nathan E. Wright , Zheng-Yu Yang , Sheila M. Zipfel
IPC: C07D487/04
Abstract: A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
-
公开(公告)号:US09873680B2
公开(公告)日:2018-01-23
申请号:US14836774
申请日:2015-08-26
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Eda Canales , Randall L. Halcomb , Yunfeng Eric Hu , Darryl Kato , John O. Link , Qi Liu , Roland D. Saito , Winston C. Tse , Jennifer R. Zhang
IPC: C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D493/04 , C07D498/04 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , C07D519/00
CPC classification number: C07D401/14 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , A61P31/18 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D493/04 , C07D498/04 , C07D519/00
Abstract: Compounds of formula I: or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
-
公开(公告)号:US20160083368A1
公开(公告)日:2016-03-24
申请号:US14836774
申请日:2015-08-26
Applicant: Gilead Sciences, Inc.
Inventor: Gediminas Brizgys , Eda Canales , Randall L. Halcomb , Yunfeng Eric Hu , Darryl Kato , John O. Link , Qi Liu , Rpland D. Saito , Winston C. Tse , Jennifer R. Zhang
IPC: C07D401/14 , A61K45/06 , A61K31/4439 , C07D471/04 , A61K31/444 , C07D493/04 , A61K31/4709 , C07D403/14 , C07D405/14 , C07D413/14 , A61K31/5377 , A61K31/496 , A61K31/506 , C07D519/00
CPC classification number: C07D401/14 , A61K31/4439 , A61K31/444 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/06 , A61P31/18 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D493/04 , C07D498/04 , C07D519/00
Abstract: Compounds of formula I: or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Abstract translation: 公开了式I化合物或其盐。 还公开了包含式I化合物的药物组合物,制备式I化合物的方法,可用于制备式I化合物的中间体和用于治疗包括HIV病毒引起的感染的逆转录病毒科病毒感染的治疗方法。
-
-
-
-
-
-
-
-
-